<!DOCTYPE html>
<meta charset="utf8" />
<html>
<script src="https://cdnjs.cloudflare.com/ajax/libs/jsdiff/5.2.0/diff.min.js"></script>
<link
  rel="stylesheet"
  href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css"
/>
<body>
    <header><h1>QuiVoteQuoi?</h1></header>
    <main>
        <section>
            <a href="/">⟵ Retourner à la recherche</a>
            <h2>Resolution on Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole</h2>
            
            <ul>
                
                <li><a href="/vote/108840">B9-0103/2019 - Proposition de résolution</a></li>
                
            </ul>
        </section>
    </main>
</body>
</html>